Andrew J. Schwab, 10% Owner at Pear Therapeutics, Inc. (PEAR), sold 774,327 shares at $1.55 ($1.3M) on 2022-08-18, disclosed to the SEC on 2022-08-18.
Open-market sale of $1.3M PEAR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.78 | 6,686 | $12K | 0.9% |
| 2 | $1.78 | 160,476 | $286K | 22.4% |
| 3 | $1.78 | 160,476 | $286K | 22.4% |
| 4 | $1.71 | 403 | $689 | 0.1% |
| 5 | $1.71 | 9,674 | $17K | 1.3% |
| 6 | $1.55 | 8,910 |
| $14K |
| 1.1% |
| 7 | $1.55 | 213,851 | $331K | 26.0% |
| 8 | $1.55 | 213,851 | $331K | 26.0% |
| Total | $1.65 avg | 774,327 | $1.3M | 100% |
| Filing → |
| CAMP | SELL | 2026-08-31 | $1.6M | — | Filing → |
| CAMP | SELL | 2026-08-26 | $45 | — | Filing → |
| CAMP | SELL | 2026-08-21 | $880K | — | Filing → |